China Hastens New Drug Development, Bayer Starts 20 New Clinical Trials
This article was originally published in PharmAsia News
Executive Summary
Bayer HealthCare China President Li Xilie, revealed April 28 that Bayer Schering Pharma started 20 new drug clinical trials in China last year
You may also be interested in...
Bayer Schering Forges Women's Health Research Partnership With Beijing's People's Liberation Army General Hospital
PERTH, Australia - Bayer Schering Pharma AG has forged a long-term strategic research partnership in the area of women's health with the People's Liberation Army General Hospital, known as 301 Hospital, in Beijing
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.